In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Focus on National Prevention Strategies: Georgia

Professor Revaz Tataradze, National CVD Prevention Coordinator in Georgia

"The role of the National CVD Prevention Coordinators become increasingly important for closing the loop between guidelines, clinical practice and political action, especially with the launch of the 5th Joint Task Force Guidelines on Cardiovascular Prevention in Clinical Practice at EuroPRevent 2012 in Dublin" says Professor Revaz Tataradze, National CVD Prevention Coordinator in Georgia

Risk Factors and Prevention

At this stage, implementation strategies at national level include adaptation of the European Guidelines to suit the local culture in collaboration with a multi-disciplinary implementation group.

This group was formed under the leadership of the Georgian National Cardiac Society and myself as National Coordinator and consists in addition of:

  • Other National Societies and organisations active in the field of CVD prevention like family medicine or hypertension
  • A senior representative of the department of Non-communicable Diseases at the National Center of Disease Control and Public Health

This group is supported by the Health Care Improvement (HCI) Project of US Agency of International Development (USAID), implemented by the University Research Co, LLC (URC), headquartered in Bethesda, Maryland, USA, along with its non-profit affiliate Center for Human Services (CHS).  

Five representatives of the implementation group started to work on coordinating the development of CVD Prevention tools at national level and the mentioned HCI Project. The goal of HCI in Georgia is to support the health sector in improving quality of services with a focus on Non-Communicable Diseases.

Members of the alliance are working very closely with the Georgian HCI project team and US Georgian Medical Diaspora in the US to develop and/or review the evidence-based clinical protocol(s) in project, priority clinical focus areas.

Specific protocols will be developed and reviewed including:

  • Screening and modificaiton of CVD risk factors
  • Management of the Metabolic Syndrome
  • Clinical management of primary hypertension in adults like
    • Measurement of Blood Pressure in Adults
    • Clinical Assessment of Adult Patients with Hypertension
    • Initiation of Treatment of Hypertension

In my function as National CVD Prevention Coordinator in Georgia I will act as a direct and privileged contact with the EACPR for national implementation and hope to contribute to the development, adaptation and promotion of country-specific version of HeartScore, to negotiate CME accreditation of CVD prevention tools at national level and to work actively with local Health Authorities to promote the implementation of the European Heart Health Charter initiative in-country.

For more information, please contact:

Professor Revaz Tataradze
National Coordinator on CVD Prevention in Georgia

Dr. Tamar Chitashvili, MD
MHP&M, Country Director of University Research Co. LLC,Medical Care Quality Improvement in Georgia, USAID Health Care Improvement Project